Bipolar hemostatic forceps in iatrogenic papillary bleeding: Utility of a third-space endoscopic device in a very different scenario
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S387-S388
DOI: 10.1055/s-0046-1821317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von Á Terán und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Problem to solve Iatrogenic papillary bleeding (IPB) is a relatively common (1-2% post-sphyncterotomy -PS- and 10% post-ampullectomy) and potentially a life-threatening endoscopic complication. Despite many endoscopic treatments available, literature is scarce about the best and more efficient option. Innovation Hemostatic bipolar forceps (HBF) Hemostat TM , a common third-space endoscopy device for vessel precoagulation and/or bleeding treatment, is a new kid on the block in the setting of IPB with first 2 case reports published in 2024. Nevertheless, HBP presents some attractive features for this scenario: 1) good functionality through duodenoscope elevator, 2) possibility of clamping the bleeding point to properly define it, 3) bipolar current with fewer surrounding energy application and 4) costs [ 1 ] [ 2 ] [ 3 ]. Results Twenty two cases of IPB (81.8% intraprocedural and 18.2% delayed) were treated by HBF in 21 patients by 2 experienced endoscopists in a 2-year period from June-2023 to June-2025. Patients were 82.7% female, mean age 76.4±12.71 and ASA III-IV: 52.4%. Initial procedure was ERCP+ES and/or precut in 81.8% and ampullectomy in 18.2%. Severity of IPB was classified as AGREE III in 95.5% and AGREE V in 4.5%. Procedural and technical data are presented in [ Table 1 ]. Table 1 Total (N: 22) Intraprocedural (n: 18) Delayed (n: 4) Active bleeding 95.5% 100% 75% HBF as single treatment 40.9% 44.4% 25% Combined therapy HBF+1 36.4% 33.3% 50% HBF+≥2 22.7% 22.2% 25% Type of combined therapies Epinephrine washing 27.3% 27.8% 25% Clipping 27.3% 27.8% 25% Stent 22.7% 22.2% 25% Others 13.6% 11.1% 25% HBF technical success 100% 100% 100% Hemostatic success Atributable to HBF 80.9% 83.3% 50% Total 100% 100% 100% HBF related complications 0% 0% 0% Bleeding recurrence 13.6% 11.1% 25% Conclusions BHF seems to be a safe and effective treatment for IPB. These results, its functionality through the duodenoscope and its electrophysical properties made the BHF appear as an attractive tool for IPB. Video http://data.process.y-congress.com/ScientificProcess/Data//106/660/1670/b0f24690-dcef-4318-aaa5-858282467188/Uploads/19990_PINZA_ESGE%20OK.mp4 Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Terán, Á., Moris, M., Duque, J. C. R., Fraile-Lopez, M., Ramos, L. M., & Arias, M. J. L. (2026). Bipolar hemostatic forceps in iatrogenic papillary bleeding: Utility of a third-space endoscopic device in a very different scenario. Endoscopy, 58(S 03 S 03), S387-S388. https://doi.org/10.1055/s-0046-1821317
Vancouver
Terán Á, Moris M, Duque JCR, Fraile-Lopez M, Ramos LM, Arias MJL. Bipolar hemostatic forceps in iatrogenic papillary bleeding: Utility of a third-space endoscopic device in a very different scenario. Endoscopy. 2026;58(S 03 S 03):S387-S388. doi:10.1055/s-0046-1821317
BibTeX
@article{Tern2026,
author = {Terán, Á and Moris, M and Duque, J C Rodríguez and Fraile-Lopez, M and Ramos, L Martín and Arias, M J López},
title = {Bipolar hemostatic forceps in iatrogenic papillary bleeding: Utility of a third-space endoscopic device in a very different scenario},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S387--S388},
doi = {10.1055/s-0046-1821317}
}
EUVIMED